Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global In-Vitro Diagnostic Testing Services 2017-2022 Including Cardiac, Molecular Diagnostic and Genomic - Research and Markets

Research and Markets
Posted on: 03 Oct 17

The "In Vitro Diagnostic Testing Services including Cardiac, Molecular Diagnostic and Genomic. Strategies & Trends. Price & Volume Forecasts by Laboratory Department by Country. 2017 to 2022 - Global Version" report has been added to Research and Markets' offering.

A market that just keeps on growing. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics.

This report provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current 2017 United States Medicare Fee Payment Schedules to help sharpen your pricing. Make facilities planning decisions. Forecast demand for new testing regimes or technologies. Make research investment decisions.

Exciting technical developments especially in the area of molecular diagnostics and pharmacogenomics hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage.

Assistance in providing specific growth and market size estimates for new technology tests is normally provided without additional charges. Existing laboratories and hospitals can use the information directly to forecast and plan for clinical facilities growth. Again, assistance in using the information is normally provided without additional charges.

A range of dynamic trends are pushing market growth and company valuations.

Trends like:

  • changing demographics
  • emerging economies and global prosperity
  • biotechnology advances in genetics
  • healthcare expansion in China
  • climate change
  • globalization
  • automation

Key Topics Covered:

1. Introduction and Market Definition

2. Overview of a Dynamic Market

3. Trends Driving a Changing Market

4. Laboratory, Molecular Diagnostics and Genomic Testing Recent Developments

5. Country Market Sizes - North America 2014 to 2022

6. Country Markets - Europe 2014 to 2022

7. Country Markets - Asia Pacific 2014 to 2022

8. Country Markets - Latin America, Africa & The Middle East 2014 to 2022

9. Global Market Summary 2014 to 2022

10. The Future of the Clinical Laboratory

Companies Mentioned

  • Abbott Laboratories
  • Acibadem Labmed Laboratory
  • ACM Medical Laboratory
  • Bio-Rad Laboratories
  • CombiMatrix
  • CompuNet Clinical Laboratories, LLC
  • Covance
  • Diagnosticos da America (DASA)
  • Dian Diagnostics
  • Digipath
  • DL Reference Laboratory
  • Gribbles Pathology
  • Grifols
  • Hologic
  • Illumina
  • Mars, Incorporated
  • Mid America Clinical Laboratories, LLC
  • Miraca Life Sciences, Inc.
  • Mount Sinai
  • Myriad Genetics, Inc.
  • NeoGenomics
  • Psychemedics Corp.
  • Pyxant Labs
  • Quest Diagnostics
  • RainDance Technologies
  • Rubicon Genomics
  • Rx30
  • The Doctor's Laboratory (Sonic Healthcare U.K.)
  • Theranos
  • Transgenomic
  • Unilabs SA
  • VCA Inc.
  • Viewics
  • Viracor Laboratories

For more information about this report visit https://www.researchandmarkets.com/research/n6fxkf/in_vitro

View source version on businesswire.com: http://www.businesswire.com/news/home/20170925005628/en/

Business Wire
www.businesswire.com

Last updated on: 03/10/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.